Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 16351668)

1.
2.

[Ezetimibe: from pharmacology to clinical trials].

Tellier P.

Ann Endocrinol (Paris). 2003 Dec;64(6):442-7. Review. French.

PMID:
15067249
3.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
4.
5.

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.

Mikhailidis DP, Lawson RW, McCormick AL, Sibbring GC, Tershakovec AM, Davies GM, Tunceli K.

Curr Med Res Opin. 2011 Jun;27(6):1191-210. doi: 10.1185/03007995.2011.571239. Epub 2011 Apr 7. Review.

PMID:
21473671
6.

Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.

Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M.

Clin Cardiol. 2003 Nov;26(11):509-14. Review.

PMID:
14640465
8.
9.

Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tablet.

Cole P, Rabasseda X.

Drugs Today (Barc). 2005 May;41(5):317-27. Review.

PMID:
16082429
10.

Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia.

Murdoch D, Scott LJ.

Am J Cardiovasc Drugs. 2004;4(6):405-22. Review.

PMID:
15554726
11.

[The role of intestinal absorption blockade in hypercholesterolemia treatment].

Diz-Lois F.

Rev Clin Esp. 2004 Oct;204(10):554-60. Review. Spanish. Erratum in: Rev Clin Esp. 2004 Dec;204(12):663.

PMID:
15456613
12.

HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin.

Mikhailidis DP, Wierzbicki AS.

Curr Med Res Opin. 2000;16(2):139-46. Review.

PMID:
10893658
13.

Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.

Lyseng-Williamson KA.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):49-56. doi: 10.2165/11209150-000000000-00000. Review.

PMID:
22208355
14.

Are Canadian guidelines for cholesterol lowering in high-risk patients optimal?

Fitchett DH, Leiter LA, Tardif JC, Goodman S, Langer A.

Can J Cardiol. 2005 Jan;21(1):85-90. Review.

PMID:
15685308
15.

Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy.

Miettinen TA.

Int J Clin Pract. 2001 Dec;55(10):710-6. Review.

PMID:
11777299
16.

The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?

Doggrell SA.

Expert Opin Pharmacother. 2012 Jul;13(10):1469-80. doi: 10.1517/14656566.2012.696098. Review.

PMID:
22725704
17.

Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years.

Lioudaki E, Ganotakis ES, Mikhailidis DP.

Curr Vasc Pharmacol. 2011 Jan;9(1):62-86. Review.

PMID:
21044019
18.

Comparison of efficacy and cost among lipid-lowering agents in patients with primary hypercholesterolemia.

Lacour A, Derderian F, LeLorier J.

Can J Cardiol. 1998 Mar;14(3):355-61. Review.

PMID:
9551029
19.

Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management.

Leitersdorf E.

Int J Clin Pract. 2002 Mar;56(2):116-9. Review.

PMID:
11926698
20.

Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.

Toth PP, Davidson MH.

Expert Opin Pharmacother. 2005 Jan;6(1):131-9. Review.

PMID:
15709890
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk